Delcath Systems Secures $35M Following FDA Approval of HEPZATO KIT
Delcath Systems, Inc., an interventional oncology company, has secured approximately $35 million through the exercise of Tranche A…
Day: September 4, 2023
2 posts
ModuleMD Acquires Diversified Health Care Management and MedEase, Bolstering Its Position in the RCM Landscape
ModuleMD, a prominent healthcare technology firm, has announced the acquisition of Diversified Health Care Management, Inc. and MedEase…